MedTrace Logo

Safety and Effectiveness of the Qualis Contact Lens

NCT04295499 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2023-10-19

Study results available
· View outcomes & findings →

Summary

Three-month, open-label, bilateral, parallel group, randomized, daily wear contact lens dispensing study.

Conditions

  • Refractive Errors

Interventions

DEVICE

soft (hydrophilic) contact lens

The intervention is a daily wear soft contact lens

Sponsors & Collaborators

  • Unicon Optical Co. Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2021-01-28
Completion
2021-01-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04295499 on ClinicalTrials.gov